The aim of this one-day interdisciplinary event is to broaden the visibility of "traditional" HMO research and, by focusing on HMOs as bioactive substances in pregnancy, to further establish this specific and innovative context of HMO research.
Human milk oligosaccharides (HMO), important pregnancy and lactation-specific factors, are known for their prebiotic, anti-infective and immunomodulating effects, among other things. Since the previous points of contact of HMO research were mainly neonatology, pediatrics and pediatric nutrition, this symposium is intended to bridge the gap to other disciplines such as feto-maternal medicine, perinatology and fetal programming, but also cardiovascular medicine, immunology and metabolic diseases. This should stimulate and continue the discussion of fundamentally new ideas and innovative collaborations.
Lectures by leading international experts cover topics on:
- HMO research in the context of breast milk and lactation
- HMO research in the new context of pregnancy and fetal imprinting
Submission deadline for poster abstracts: March 21st
Language: English
"DFP" Medical Points: 8
